Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, November 27, 2014
Technology Networks
Register | Sign in
Home Page>News

  News Archive

Almac Announces Launch of CLIA Validated Next Generation Sequencing Assay
Thursday, November 13, 2014
P53 considered important biomarker for cancer drug discovery.

Advent International Sign Agreement with Avista Capital Partners
Thursday, November 13, 2014
Agreement to acquire Kremers Urban Pharmaceuticals from UCB.

ICON Selected by the FDA to Develop New PRO Measure for HABP Trials
Thursday, November 13, 2014
New PRO measure being developed in conjunction with the FNIH Biomarkers Consortium.

Charles River and CHDI Foundation Extend Huntington’s Disease Collaboration
Thursday, November 13, 2014
CHDI extends its ongoing collaboration for an additional five years through to 2019.

West Receives 510(k) Clearance for NovaGuard™ SA Safety System
Thursday, November 13, 2014
Staked-needle prefillable syringe safety system helps reduce risk of needlestick injury to healthcare workers and patients.

GE Healthcare and Takeda Join Forces
Thursday, November 13, 2014
This alliance is key to enabling the early development of therapeutic drugs through the use of a minimally invasive diagnostic technology.

PAREXEL Expands Clinical Trial Supply and Logistics Services
Thursday, November 13, 2014
Facility in Berlin-Schönefeld, Germany delivers end-to-end supply chain management and distribution services.

Cirrus Pharmaceuticals to Invest in cGMP Manufacturing Suite in US
Thursday, November 13, 2014
Company will be able to extend its offerings in the US from contract development to manufacturing.

Theorem Clinical Research Expands Leadership and Prepares for Growth
Thursday, November 13, 2014
Addition of Kathryn Bohannon as vice president of biopharmaceutical development and Angela Weston as vice president business development.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 3278
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to